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Introduction: Synchronous embolism to the superior mesenteric artery (SMA) and coeliac axis (CA) is
a rare disease.
Report: A 67-year-old man with atrial ﬁbrillation developed acute liver failure due to an embolic
occlusion of the CA and SMA, with a severe coagulation disorder. He was successfully managed with
percutaneous stent placement and an exploratory laparotomy was not needed. He remains symptom-
free 1 year after the procedure, and duplex follow-up showed stent patency.
Conclusion: Endovascular techniques in patients with liver failure, no signs of peritonism, early diagnosis
and high operative risk seem feasible and should be used if possible, as ﬁrst-line option.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.The survival rate of liver and mesenteric ischaemia has not
improved substantially during the past years, despite the advances
in open surgery and endovascular techniques.1 Endovascular ther-
apies include different techniques, such as catheter-directed vaso-
dilator, aspiration thrombolytic therapy, endovascular angioplasty
or stent placement.Report
A 67-year-old man with a nephrectomy done the previous day
presented with a history of acute liver failure and mid-to-upper
abdominal pain. The patient’s medical history was signiﬁcant for
an atrial ﬁbrillation. An urgent computed tomography (CT) angi-
ography revealed a coeliac trunk and superior mesenteric artery
(SMA) occlusion. On physical examination, he had absent periton-
ism signs. Laboratory data revealedmetabolic acidosis, leucocytosis
(14,580  103 ml1) and elevated levels of lactate (55 mg dl1),
aspartate aminotransferase (AST, 4337 U l1), alanine aminotrans-
ferase (ALT, 2190 U l1), lactate dehydrogenase (LDH, 10170 U l1),
International normalised ratio (INR) 3.73 and activated partial
thromboplastin time (aPTT, 59 s).
An anterioposterior and lateral aortogram was performed via
the transfemoral approach (Fig. 1). A Simmons 1 catheter (Bard
Angiomed, Karlsruhe, Germany) was used to select the expectedSan Norberto).
ciety for Vascular Surgery. Publisheorigin of the SMA. The occlusion could then be crossed with
a 0.035-inch hydrophilic wire (Radiofocus M; Terumo, Leuven,
Belgium). The technique included placement of an 8  59-mm
balloon-expandable stent (Omnilink Elite, Abbott Vascular
Devices, Ulestraten, the Netherlands) across the occlusion without
predilation, introduced over a stiff guide wire (Amplatz Super Stiff;
Boston Scientiﬁc, Natick, MA, USA) to prevent a prolapse into the
aorta. A left brachial approach was added to improve the angle of
entry into the ostia of the coeliac axis (CA) and because of the acute
angle of entry into the CA from the femoral approach. A 5-F cobra-
shaped catheter (Bard Angiomed, Karlsruhe, Germany) with a less
traumatic 0.014-inch wire (Spartacore 14, Abbott Vascular Inter-
national, Diegem, Belgium) was employed to cross the occlusive
lesion. Once the wire was placed across the occlusion, a catheter
(CXI Support Catheter, Cook Medical, Bloomington, IN, USA) was
carefully advanced over the wire across the lesion and a second
stiffer wire (Amplatz Super Stiff; Boston Scientiﬁc, Natick, MA, USA)
was exchanged through the catheter to facilitate the placement of
a 8  59-mm balloon-expandable stent (Omnilink Elite, Abbott
Vascular Devices, Ulestraten, the Netherlands). A subsequent
arteriogram conﬁrmed an excellent ﬂow to the liver territory.
The patient was haemodynamically stable and a persistently
normal abdominal examination was presented. On the ﬁrst post-
interventional day, lactic acid decreased to 20 mg dl1; coagula-
tion and liver function returned to normal values on the third
postoperative day. An angio CT examination showed normal
patency of the CA and SMA (Fig. 2). The patient was dischargedwith
oral anticoagulant therapy and 100 mg of aspirin daily indeﬁnitely.d by Elsevier Ltd. All rights reserved.
Figure 1. Digital subtraction angiography. A: Abrupt cutoff of the SMA with the absence of collateral circulation (continuous arrow) and complete occlusion of the CA (doted arrow).
B: Image during ﬂuoroscopy shows an Amplatz wire selecting the SMA after selective ﬁbrinolysis. C: Wire across CA occlusion and a stent in the SMA showing normal ﬂow. D: CA
stent placement without predilation.
Figure 2. A: Preoperative CT scan shows occlusion of CA and SMA. B: 3D reconstruction computed tomography angiogram (CT) 5 days post CA and SMA stenting. Adequate luminal
patency of the coeliac artery and hepatic artery is seen.
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haemodynamically signiﬁcant residual stenosis.
Discussion
Acute mesenteric ischaemia is a life-threatening surgical
emergency associated with high morbidity and mortality rates.
Atrial ﬁbrillation, SMA occlusion and synchronous embolism are
common ﬁndings. Acosta et al. reported that visceral synchronous
embolism occurred in 113 of 273 (41%) arterial segments, of which
10 emboli were lodged in the coeliac trunk.2
Previously, endovascular treatment was not applied to patients
presenting with acute mesenteric arterial thrombosis because it
does not allow for bowel viability assessment, requires advanced
endovascular surgery skills and procedure time can delay revas-
cularisation. The advantages of endoluminal techniques include
timely visualisation of the affected vascular anatomy with near-
immediate restoration of ﬂow and replacement of the need for
open surgical reconstruction, avoiding aortic clamping and pros-
thetic conduit contamination.
The systematic review of Schoots et al.3 suggested that catheter-
directed ﬁbrinolysis with urokinase may serve as an adjunctive
treatment modality to surgery. Indication requires no development
of peritonitis and good collaterals in arteriography. SMA percuta-
neous transluminal angioplasty (PTA) can achieve a rapid recanal-
isation more quickly than primary thrombolysis. Peripheral
embolisation of the thrombus partly dissolved and broken by PTA is
the most likely complication of PTA. Stenting could avoid this risk
for distal embolisation. Successful endovascular treatment was
associated with improved mortality compared with traditional
therapy (36% vs. 50%).4 The technique called ‘retrograde superiormesenteric artery stenting’ (ROMS) combines both open surgical
and endovascular methods.
According to the literature, this seems to be the ﬁrst case of an
acute liver failure due to a combined thrombo-embolic occlusion
of CA and SMA treated with stenting. In the largest single-centre
experience published,5 liver function alterations were rare, with
AST mean value of 25 U l1 (18e35) and ALT of 20 U l1 (11e39).
In our opinion, endovascular treatment in patients with liver
failure, no signs of peritonism, early diagnosis and high operative
risk, seems feasible and should be used if possible, as ﬁrst-line
option.
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